网站大量收购独家精品文档,联系QQ:2885784924

Multiple risk factors for diabetes control.doc

  1. 1、本文档共4页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Multiple risk factors for diabetes control

 PAGE \* MERGEFORMAT 4 Multiple risk factors for diabetes control [Keywords:] diabetes, multiple risk factors, control Study confirmed that strict glycemic control can reduce the incidence of diabetic microangiopathy. But some studies found evidence-based medicine in the prevention of cardiovascular complications of diabetes, the only good blood glucose control is not enough, even controlling for other risk factors, it is because of diabetes As part of the metabolic syndrome, gathered a large number of risk factors for cardiovascular disease include high blood glucose, lipid metabolism disorders, hypertension, central obesity, and chronic inflammation, hypercoagulable state, etc., these risk factors for atherosclerosis in the arteries formation. insulin resistance metabolic syndrome exists as the soil, which is not only the occurrence of atherosclerosis in the initiating part, but also accelerated the development of atherosclerosis. At present the development of oral hypoglycemic agents, have begun to focus on its other hypoglycemic benefits of reducing cardiovascular disease risk factors. 1 antihyperglycemic effect of drugs on cardiovascular Cardiovascular protective effect of metformin on plasma non-esterified fatty acids, including lower levels, improve blood lipids, reduce fat deposition in the vascular wall, inhibit vascular smooth muscle cell proliferation, anti-oxidative stress, lower blood viscosity and so on. Its beneficial cardiovascular role in the UKPDS study has confirmed. in the U.S. Diabetes Prevention Study (DPP found that metformin was also effective in treatment of central obesity, improve the response rate of metabolic syndrome. Studies have shown that TZDs drugs thiazolidinediones (TZDs can decrease the blood of patients with type 2 diabetes small and dense low-density lipoprotein cholesterol, C-reactive protein, matrix metalloproteinase -9, plasminogen activator inhibitor -1 levels, increased high-density lipoprotein choleste

文档评论(0)

jiupshaieuk12 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档